153 related articles for article (PubMed ID: 33198521)
1. Impact of perceived contraceptive policy changes on long acting reversible contraception dispensing trends.
Sridhar A; Friedman SR; Sim MK; Troung W; Elias S
Eur J Contracept Reprod Health Care; 2021 Feb; 26(1):58-61. PubMed ID: 33198521
[TBL] [Abstract][Full Text] [Related]
2. Adherence to Recommended Practices for Provision of Long-Acting Reversible Contraception Among Providers in a Large U.S. Health Care System.
Judge-Golden CP; Wiesenfeld HC; Chen BA; Borrero S
J Womens Health (Larchmt); 2020 Dec; 29(12):1586-1595. PubMed ID: 32667847
[No Abstract] [Full Text] [Related]
3. Factors Associated with New Uptake of Long-Acting Reversible Contraceptives Since the Affordable Care Act Among Privately Insured Women in Pennsylvania.
Nelson HN; Thayer E; Bailey C; Leuenberger L; Lehman E; Chuang CH
Womens Health Issues; 2019; 29(5):370-375. PubMed ID: 31337530
[TBL] [Abstract][Full Text] [Related]
4. Not seeking yet trying long-acting reversible contraception: a 24-month randomized trial on continuation, unintended pregnancy and satisfaction.
Hubacher D; Spector H; Monteith C; Chen PL
Contraception; 2018 Jun; 97(6):524-532. PubMed ID: 29470950
[TBL] [Abstract][Full Text] [Related]
5. Impact of the Rochester LARC Initiative on adolescents' utilization of long-acting reversible contraception.
Aligne CA; Phelps R; VanScott JL; Korones SA; Greenberg KB
Am J Obstet Gynecol; 2020 Apr; 222(4S):S890.e1-S890.e6. PubMed ID: 31978438
[TBL] [Abstract][Full Text] [Related]
6. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
[TBL] [Abstract][Full Text] [Related]
7. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
[TBL] [Abstract][Full Text] [Related]
8. Cost-benefit analysis of enhancing the uptake of long-acting reversible contraception in Australia.
Concepcion K; Lacey S; McGeechan K; Estoesta J; Bateson D; Botfield J
Aust Health Rev; 2020 Jun; 44(3):385-391. PubMed ID: 31655632
[TBL] [Abstract][Full Text] [Related]
9. Use of Immediate Postpartum Long-Acting Reversible Contraception Before and After a State Policy Mandated Inpatient Access.
Brant AR; Kollikonda S; Yao M; Mei L; Emery J
Obstet Gynecol; 2021 Nov; 138(5):732-737. PubMed ID: 34619694
[TBL] [Abstract][Full Text] [Related]
10. Current evidence of contraceptive uptake, pregnancy and continuation rates in young women: a systematic review and Meta-analysis.
Farah D; Andrade TRM; Di Bella ZIKJ; Girão MJBC; Fonseca MCM
Eur J Contracept Reprod Health Care; 2020 Dec; 25(6):492-501. PubMed ID: 33140990
[TBL] [Abstract][Full Text] [Related]
11. The relationship between long-acting reversible contraception and insurance coverage: a retrospective analysis.
Broecker J; Jurich J; Fuchs R
Contraception; 2016 Mar; 93(3):266-72. PubMed ID: 26577755
[TBL] [Abstract][Full Text] [Related]
12. Impact of a pay-for-performance scheme for long-acting reversible contraceptive (LARC) advice on contraceptive uptake and abortion in British primary care: An interrupted time series study.
Ma R; Cecil E; Bottle A; French R; Saxena S
PLoS Med; 2020 Sep; 17(9):e1003333. PubMed ID: 32925909
[TBL] [Abstract][Full Text] [Related]
13. Predictors of choosing long-acting reversible contraceptive methods when provided free-of-charge - A prospective cohort study in Finland.
Gyllenberg F; Saloranta T; But A; Gissler M; Heikinheimo O
Contraception; 2020 Jun; 101(6):370-375. PubMed ID: 32061566
[TBL] [Abstract][Full Text] [Related]
14. Association Between Women's Use of Long-Acting Reversible Contraception and Declining Abortion Rates in New Zealand.
Whitley CE; Rose SB; Sim D; Cook H
J Womens Health (Larchmt); 2020 Jan; 29(1):21-28. PubMed ID: 31600111
[No Abstract] [Full Text] [Related]
15. Eliminating health disparities in unintended pregnancy with long-acting reversible contraception (LARC).
Parks C; Peipert JF
Am J Obstet Gynecol; 2016 Jun; 214(6):681-8. PubMed ID: 26875950
[TBL] [Abstract][Full Text] [Related]
16. The Availability and Use of Postpartum LARC in Mexico and Among Hispanics in the United States.
Potter JE; Hubert C; White K
Matern Child Health J; 2017 Sep; 21(9):1744-1752. PubMed ID: 27562799
[TBL] [Abstract][Full Text] [Related]
17. Society for Maternal-Fetal Medicine (SMFM) Consult Series #48: Immediate postpartum long-acting reversible contraception for women at high risk for medical complications.
; Vricella LK; Gawron LM; Louis JM
Am J Obstet Gynecol; 2019 May; 220(5):B2-B12. PubMed ID: 30738885
[TBL] [Abstract][Full Text] [Related]
18. The effect of an educational video on long-acting reversible contraception (LARC) utilization at 6-8 weeks postpartum period: a randomized controlled trial.
Burapasikarin C; Manonai J; Wattanayingcharoenchai R
Arch Gynecol Obstet; 2020 Dec; 302(6):1503-1509. PubMed ID: 32734413
[TBL] [Abstract][Full Text] [Related]
19. Motivational interviewing to promote long-acting reversible contraception among Rwandan couples wishing to prevent or delay pregnancy.
Mukamuyango J; Ingabire R; Parker R; Nyombayire J; Easter SR; Wall KM; Tichacek A; Nyirazinyoye L; Kaslow N; Allen S; Karita E
Am J Obstet Gynecol; 2020 Apr; 222(4S):S919.e1-S919.e12. PubMed ID: 31838122
[TBL] [Abstract][Full Text] [Related]
20. Examining long-acting reversible contraception non-use among Australian women in their 20s: findings from a qualitative study.
Coombe J; Harris ML; Loxton D
Cult Health Sex; 2019 Jul; 21(7):822-836. PubMed ID: 30612512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
